Topic Roche

Companies Roche

Products Roche

Gene expression analysis and genomic variation detection

Like all LightCycler® Instruments, the LightCycler® Nano produces high quality qPCR, genotyping and high resolution melting data using easy-fit reagents, reaction vessels and instrumentation more

LightCycler® Real-Time PCR Systems for EHEC identification

Fast, reliable detection of the EHEC bacterium is essential for monitoring and controlling EHEC infections. The most appropriate targets for the rapid more

News Roche

• Roche Steps Back from Illumina Acquisition

  F. Hoffman-La Roche dropped its bid to buy Illumina after Illumina’s shareholders made it clear at the company’s annual meeting that the terms were inadequate. Roche had made a $51 per share tender offer for San Diego-based Illumina, but allowed the offer to expire. GlobalData analyzed the proceedin more

• Sysmex and Roche renew successful alliance in the hematology business

  Sysmex Corporation and Roche announced the signing of a restated 10 years distribution, sales and services agreement (“DSS Agreement”). Under the agreement, Roche will continue to distribute the Sysmex hematology products, including instruments, reagents and data management solutions in selected cou more

• 'Cancer Drug Market Will Reach $75 Billion in 2012' visiongain Report Predicts

  A new report by visiongain predicts that the world market for cancer-treating drugs will reach $75 billion for 2012. That revenue forecast appears in Leading Anti-Cancer Drugs and Associated Market 2012-2022, published in February 2012. The new study predicts that overall revenues for anti-cancer tr more

White papers Roche

• Continuous non-invasive real-time cell monitoring in 384-well plates
  

  Roche’s xCELLigence System RTCA HT Instrument performs real-time impedance-based label-free measurement of cell behavior for high throughput applications. It´s technology is compatible with workflows carrying out automated screening using the 384-well culture plate format more

• Non-Invasive Real-Time Cell Analytics for Drug Discovery
  

  Roche’s xCELLigence Cardio Instrument is a medium-throughput cell analyzer using impedance recording to monitor cardiac beating and cellular events in real time. The instrument features high resolution detection rate and frequency measurement technology driven by dedicated software. Unlike patch clamp recordings, this system monitors cardiac cell responsivity continuously in both short-term and more

• Continuous Real-Time Cell Monitoring in 16- and 96-Well Plates
  

  The xCELLigence System is a microelectronic biosensor system for cell-based assays, providing dynamic, real-time, label-free cellular data for a variety of research applications in drug development, toxicology, cancer research, medical microbiology, and virology. Exceeding the limits of endpoint analysis, data how cells are responding are obtained during the entire experiment more

Publications Roche

• Proteins under pressure [Commentary]

  Today, 3D models of proteins are often constructed entirely by a computer. Building old-fashioned wire models may have been time-consuming, but it was not drudgery. To the contrary, it was a labor of love. One could not fail to marvel at the way in which the successive amino acids fitted together, w more

• Sample richness and genetic diversity as drivers of chimera formation in nSSU metagenetic analyses

  Eukaryotic diversity in environmental samples is often assessed via PCR-based amplification of nSSU genes. However, estimates of diversity derived from pyrosequencing environmental data sets are often inflated, mainly because of the formation of chimeric sequences during PCR amplification. Chimeras more

• Detection of Base Substitution-Type Somatic Mosaicism of the NLRP3 Gene with >99.9% Statistical Confidence by Massively Parallel Sequencing

  Chronic infantile neurological cutaneous and articular syndrome (CINCA), also known as neonatal-onset multisystem inflammatory disease (NOMID), is a dominantly inherited systemic autoinflammatory disease and is caused by a heterozygous germline gain-of-function mutation in the NLRP3 gene. We recent more

Market studies Roche

• Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more

• Global Human Growth Hormone Drugs Market 2011-2015

  TechNavio’s analysts forecast the Global Human Growth Hormone Drug market to grow at a CAGR of 3 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increase in number of people suffering from growth hormone deficiency. The Global Human Growth Hormone more

• Healthcare, Regulatory and Reimbursement Landscape - US

  Introduction Industry analysis specialist GlobalData, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the US. It identifies the key t more

Websites Roche